Literature DB >> 8052156

Altered fatty acid metabolism in patients with angiographically documented coronary artery disease.

E N Siguel1, R H Lerman.   

Abstract

Plasma lipids and fatty acids have been linked to coronary artery disease (CAD), and linoleic acid deficiency has been proposed as a risk factor for cardiovascular disease, but few studies have considered their multivariate effects or found the biochemical shifts associated with abnormal fatty acid metabolism or essential fatty acid (EFA) deficiency. We studied fatty acid patterns associated with CAD using high-resolution capillary column gas-liquid chromatography to analyze fasting plasma from 47 patients with angiographically documented CAD and 56 reference subjects. CAD patients exhibited a shift in fatty acid metabolism similar to that associated with EFA-deficient patients. Compared with reference subjects, CAD patients had (1) reduced percentages of polyunsaturated fatty acids ([PUFA] 45% v 50%, P < .001), (2) increased monounsaturated fatty acids (26% v 22%, P < .001), (3) higher ratios of Mead (20:3 omega 9) to arachidonic (20:4 omega 6) acid (0.016 v 0.013, P < .04), (4) increased levels of 16:1 omega 7 (2.10% v 1.55%, P < .001), and (5) higher concentrations of total fatty acids (356 v 284 mg/dL, P < .001), saturated fatty acids (101 v 75 mg/dL, P < .001), monounsaturated fatty acids (91 v 63 mg/dL, P < .001), PUFA (159 v 143 mg/dL, P < .01), 20:3 omega 9 (0.5 v 0.3 mg/dL, P < .01) and 16:1 omega 7 (7.7 v 4.5 mg/dL, P < .01). On indices of EFA status that depend on percentages or ratios of fatty acids or on the production of abnormal fatty acids, CAD patients were between severely EFA-deficient patients and healthy subjects, a state referred to as EFA insufficiency. Patients had metabolic shifts toward increased production of monounsaturated fatty acids and increased ratios of derivatives to precursors of omega 6 fatty acids, shifts that occur when cells are EFA-deficient. Levels of EFAs were negatively correlated with levels of saturated and monounsaturated fatty acids. The percentage of 18:2 omega 6 was positively correlated with high-density lipoprotein (HDL) cholesterol and the ratio of HDL to total cholesterol (r = .58, P < .001, and r = .61, P < .001, respectively) and negatively correlated with triglycerides and total cholesterol (r = .61, P < .001, and r = -.24, P < .01, respectively). Opposite correlations with these parameters were observed with saturated and monounsaturated fatty acids. Saturated fatty acids, total cholesterol, and indicators of EFA deficiency increased and the HDL to total cholesterol ratio and PUFA decreased the probability of CAD as measured by multivariate linear regression.(ABSTRACT TRUNCATED AT 400 WORDS)

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8052156     DOI: 10.1016/0026-0495(94)90178-3

Source DB:  PubMed          Journal:  Metabolism        ISSN: 0026-0495            Impact factor:   8.694


  12 in total

1.  A new relationship between total/high density lipoprotein cholesterol and polyunsaturated fatty acids.

Authors:  E Siguel
Journal:  Lipids       Date:  1996-03       Impact factor: 1.880

Review 2.  Is there a role for parenteral feeding in clinical medicine?

Authors:  S D Phinney; J Siepler; H T Bach
Journal:  West J Med       Date:  1996-02

3.  Human fatty acid synthesis is stimulated by a eucaloric low fat, high carbohydrate diet.

Authors:  L C Hudgins; M Hellerstein; C Seidman; R Neese; J Diakun; J Hirsch
Journal:  J Clin Invest       Date:  1996-05-01       Impact factor: 14.808

Review 4.  Paradigm shift - Metabolic transformation of docosahexaenoic and eicosapentaenoic acids to bioactives exemplify the promise of fatty acid drug discovery.

Authors:  Ganesh V Halade; Laurence M Black; Mahendra Kumar Verma
Journal:  Biotechnol Adv       Date:  2018-02-28       Impact factor: 14.227

Review 5.  Long-chain fatty acid transport in bacteria and yeast. Paradigms for defining the mechanism underlying this protein-mediated process.

Authors:  C C DiRusso; P N Black
Journal:  Mol Cell Biochem       Date:  1999-02       Impact factor: 3.396

6.  Associations of erythrocyte palmitoleic acid with adipokines, inflammatory markers, and the metabolic syndrome in middle-aged and older Chinese.

Authors:  Geng Zong; Xingwang Ye; Liang Sun; Huaixing Li; Zhijie Yu; Frank B Hu; Qi Sun; Xu Lin
Journal:  Am J Clin Nutr       Date:  2012-09-26       Impact factor: 7.045

7.  Circulating palmitoleic acid and risk of metabolic abnormalities and new-onset diabetes.

Authors:  Dariush Mozaffarian; Haiming Cao; Irena B King; Rozenn N Lemaitre; Xiaoling Song; David S Siscovick; Gökhan S Hotamisligil
Journal:  Am J Clin Nutr       Date:  2010-10-13       Impact factor: 7.045

8.  Effect of Omega-3 Fatty Acid on the Fatty Acid Content of the Erythrocyte Membrane and Proteinuria in Patients with Diabetic Nephropathy.

Authors:  Su Mi Lee; Seuk Hee Chung; Yongjin Park; Mi Kyoung Park; Young Ki Son; Seong Eun Kim; Won Suk An
Journal:  Int J Endocrinol       Date:  2015-05-18       Impact factor: 3.257

9.  Efficacy of a unique omega-3 formulation on the correction of nutritional deficiency and its effects on cardiovascular disease risk factors in a randomized controlled VASCAZEN(®) REVEAL Trial.

Authors:  Nisar A Shaikh; Jason Yantha; Sabah Shaikh; William Rowe; Maggie Laidlaw; Carla Cockerline; Abbas Ali; Bruce Holub; George Jackowski
Journal:  Mol Cell Biochem       Date:  2014-09-04       Impact factor: 3.396

10.  Variations in the lipid profile of patients with chronic renal failure treated with pyridoxine.

Authors:  Nelva T de Gómez Dumm; Ana M Giammona; Luis A Touceda
Journal:  Lipids Health Dis       Date:  2003-09-18       Impact factor: 3.876

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.